Institut National de la Recherche Scientifique-Institut Armand-Frappier, Laval, Quebec, Canada.
Institute of Parasitology, McGill University, Sainte-Anne-de-Bellevue, Quebec, Canada.
Infect Immun. 2019 Apr 23;87(5). doi: 10.1128/IAI.00064-19. Print 2019 Mar.
CXCL16 is a multifunctional chemokine that is highly expressed by macrophages and other immune cells in response to bacterial and viral pathogens; however, little is known regarding the role of CXCL16 during parasitic infections. The protozoan parasite is the causative agent of visceral leishmaniasis. Even though chemokine production is a host defense mechanism during infection, subversion of the host chemokine system constitutes a survival strategy adopted by the parasite. Here, we report that promastigotes upregulate CXCL16 synthesis and secretion by bone marrow-derived macrophages (BMDM). In contrast to wild-type parasites, a strain deficient in the virulence factor lipophosphoglycan (LPG) failed to induce CXCL16 production. Consistent with this, cell treatment with purified LPG augmented CXCL16 expression and secretion. Notably, the ability of BMDM to promote migration of cells expressing CXCR6, the cognate receptor of CXCL16, was augmented upon infection in a CXCL16- and LPG-dependent manner. Mechanistically, CXCL16 induction by required the activity of AKT and the mechanistic target of rapamycin (mTOR) but was independent of Toll-like receptor signaling. Collectively, these data provide evidence that CXCL16 is part of the inflammatory response elicited by LPG Further investigation using CXCL16 knockout mice is required to determine whether this chemokine contributes to the pathogenesis of visceral leishmaniasis and to elucidate the underlying molecular mechanisms.
趋化因子 CXCL16 是一种多功能趋化因子,在受到细菌和病毒病原体的刺激时,巨噬细胞和其他免疫细胞会高度表达该趋化因子;然而,人们对其在寄生虫感染中的作用知之甚少。原生动物寄生虫 是内脏利什曼病的病原体。尽管趋化因子的产生是感染期间宿主防御机制的一部分,但寄生虫对宿主趋化因子系统的颠覆构成了其生存策略。在这里,我们报告称, 前鞭毛体通过骨髓来源的巨噬细胞(BMDM)上调 CXCL16 的合成和分泌。与野生型寄生虫不同,缺乏毒力因子脂磷壁酸(LPG)的寄生虫株未能诱导 CXCL16 的产生。与此一致的是,用纯化的 LPG 处理细胞会增强 CXCL16 的表达和分泌。值得注意的是,BMDM 促进表达 CXCR6(CXCL16 的同源受体)的细胞迁移的能力在以 CXCL16 和 LPG 依赖的方式感染后增强。从机制上讲, 诱导 CXCL16 需要 AKT 和雷帕霉素(mTOR)的机制靶点的活性,但不依赖 Toll 样受体信号。总之,这些数据提供了证据表明 CXCL16 是由 LPG 引发的炎症反应的一部分。需要使用 CXCL16 敲除小鼠进行进一步研究,以确定这种趋化因子是否有助于内脏利什曼病的发病机制,并阐明潜在的分子机制。